🇺🇸 Ly4064809 in United States

Ly4064809 (ly4064809) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Ly4064809 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Ly4064809 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ly4064809 in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Ly4064809 cost in United States?

annual_list: USD 25000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.